Virpax Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing pharmaceutical product candidates for pain management by developing and delivering non-opioid and non-addictive pharmaceutical products. Its products include Epoladerm, OSF200, Probudur, NES100, PES200 and MMS019. Epoladermis is developed as a topical nonsteroidal anti-inflammatory drug (NSAID) treatment for acute pain. OSF200 utilizes the same transdermal delivery system as...